These results showed that cases carrying resistance mutations in EGFR accumulated abundant hyper-methylation changes in regulatory regions of tumor suppressor genes such as HOX genes to inhibit the differentiation of cancer cells during the acquisition of TKI resistance. Here, EGFR is linked to cancer.